Adtalem Global Education Inc.
ATGEOther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.79B | $1.58B | $1.45B | $1.38B | $899.2M | $866.4M |
| Operating income | $341.5M | $217.1M | $168.2M | $76.7M | $110.4M | $110.1M |
| Net income | $237.1M | $136.8M | $93.4M | $311.0M | $70.0M | −$85.3M |
| Total assets | $2.75B | $2.74B | $2.81B | $2.84B | $3.08B | $2.26B |
| Total liabilities | $1.32B | $1.37B | $1.35B | $1.33B | $1.78B | $915.4M |
| Equity | $1.43B | $1.37B | $1.46B | $1.49B | $1.29B | $1.31B |
| EPS (diluted) | $6.18 | $3.39 | $2.05 | $6.43 | $1.36 | $-1.58 |
| Shares out. | 36.0M | 37.7M | 41.5M | 45.2M | 49.6M | 51.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 19.1%
- Net margin
- 13.3%
- Return on equity
- 16.5%
- Return on assets
- 8.6%
- Return on capital (ROCE)
- 15.2%
- Liabilities / assets
- 47.9%
- Debt / equity
- 0.92×
- Book value / share
- $39.87
- Revenue growth (YoY)
- 12.9%
- Net income growth (YoY)
- 73.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 5.05safe
- Accruals / assets
- −3.7%clean
- Beneish M-Score
- -2.50normal
- Piotroski F-Score
- 8/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 7 good- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Gangadharan ManjunathOfficer — VP, Chief Accounting Officer | May 18, 2026 | Tax withholding | 426 | $127.85 |
| Phelan Robert J.Officer — Chief Financial Officer | May 8, 2026 | Sell | 10,000 | $126.21 |
| Beck Douglas G.Officer — SVP, GC, Corp. Sec & ISS | May 8, 2026 | Sell | 9,615 | $127.03 |
| Cox Karen SueOfficer — President, Chamberlain Univ. | May 8, 2026 | Sell | 2,000 | $124.50 |
| Beard, Stephen W.Officer — Chairman & CEO | May 8, 2026 | Sell | 15,874 | $131.25 |
| Liles ScottOfficer — President, Medical and Vet | Apr 15, 2026 | Tax withholding | 448 | $112.49 |
| Malafronte Michael WDirector | Mar 10, 2026 | Buy | 11,841 | $100.86 |
| Malafronte Michael WDirector | Mar 3, 2026 | Buy | 1,200 | $97.97 |
| Beard, Stephen W.Officer — Chairman & CEO | Dec 10, 2025 | Gift | 5,332 | $0.00 |
| Wardell Lisa WDirector | Nov 12, 2025 | Grant | 1,445 | $96.86 |
| Vandenbosch Betty M.Director | Nov 12, 2025 | Grant | 1,445 | $96.86 |
| Trent EvanOfficer — President, Adtalem Elevate | Nov 12, 2025 | Grant | 1,673 | $96.86 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Feb 13, 2026 | 1.8M | 3.8 | +23.3% |
| Jan 30, 2026 | 1.5M | 2.6 | +1.6% |
| Jan 15, 2026 | 1.5M | 4.3 | +2.9% |
| Dec 31, 2025 | 1.4M | 3.2 | +13.6% |
| Dec 15, 2025 | 1.3M | 2.1 | +22.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 7, 2026
- Regulation FD disclosureApr 9, 2026
- Entered a material agreement · Terminated a material agreement · New financial obligationMar 3, 2026
- Regulation FD disclosureFeb 24, 2026
- Amended charter or bylaws · Regulation FD disclosureFeb 6, 2026
- Results of operationsJan 28, 2026
- Other material eventDec 15, 2025
- Shareholder voteNov 14, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 11-KJun 1, 2026
- 3PRIMARY DOCUMENTMay 20, 2026
- 4PRIMARY DOCUMENTMay 20, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
- 144May 8, 2026
- 144/AMay 8, 2026
- 144May 8, 2026
- 144May 8, 2026
- 144May 8, 2026
- 144May 8, 2026
- 10-QMay 7, 2026
- 8-KMay 7, 2026
Event-driven situations (4)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.